Cabaletta Bio Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.19

+0.20 (+6.69%)

As of Jul 4, 10:36 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 13 81%

Hold 3 19%

Sell 0 0%

Price Target

Analyst Price Target +1,147.3% upside

Low Target $29.42

Average Target $39.79

High Target $58.63

Current Price $3.19

Current
$3.19

Target
$39.79

$29.42 $39.79 avg $58.63

Scenario Analysis

Bear Case

$29.42

822.3%

Low target

Base Case

$39.79

+1,147.3%

Avg target

Bull Case

$58.63

+1,737.9%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$4.23

-24.6% from high

52-Week Low

$1.26

+153.2% from low

Target vs 52W High

$39.79

+840.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	-1.3%
AMGN Amgen Inc	Hold	44	50%	$190.87	-49.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+176.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-17.0%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-88.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-67.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-48.8%